Home
>
National Drug Code (NDC)
>
CAMBIA
CAMBIA - 50192-113-01 - (Diclofenac Potassium)
Drug Information of CAMBIA
| Product NDC: | 50192-113 |
| Proprietary Name: | CAMBIA |
| Non Proprietary Name: | Diclofenac Potassium |
| Active Ingredient(s): | 1 mg/mg & nbsp; Diclofenac Potassium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CAMBIA
| Product NDC: | 50192-113 |
| Labeler Name: | Nautilus Neurosciences, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022165 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100420 |
Package Information of CAMBIA
| Package NDC: | 50192-113-01 |
| Package Description: | 50 mg in 1 PACKET (50192-113-01) |
NDC Information of CAMBIA
| NDC Code | 50192-113-01 |
| Proprietary Name | CAMBIA |
| Package Description | 50 mg in 1 PACKET (50192-113-01) |
| Product NDC | 50192-113 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Diclofenac Potassium |
| Dosage Form Name | POWDER, FOR SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20100420 |
| Marketing Category Name | NDA |
| Labeler Name | Nautilus Neurosciences, Inc. |
| Substance Name | DICLOFENAC POTASSIUM |
| Strength Number | 1 |
| Strength Unit | mg/mg |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
